Using Protected Health Information to Improve AI

Wednesday, April 19 at 4:00 PM - 5:00 PM CT
South Building, Level 1 | S103

Artificial intelligence offers substantial opportunities to improve the healthcare system. But large volumes of protected health information (PHI) are required to develop and improve AI algorithms. This session will explore how healthcare providers, health plans, and technology companies can navigate complex privacy laws to permissibly use PHI to improve AI, and will identify some of the high risk areas where the law is unclear or prohibits such use.

Learning Objectives

  • Describe how HIPAA applies to covered entities and business associates' use of protected health information (PHI) to develop or improve AI
  • Distinguish between uses of PHI for AI that qualify as healthcare operations versus research activities
  • Identify when a disclosure of PHI to develop or improve PHI may qualify as a prohibited sale of PHI
  • Identify the different parts of a HIPAA business associate agreement that may permit the use of patient information to develop or improve AI
  • Describe categories of PHI that may have additional restrictions and therefore may need to be excluded from AI efforts
Credits
CNE, CME, ACPE, AHIMA, CAHIMS, CPHIMS
Status
Active
Audience
Chief Data Officer, Chief Digital Officer/Chief Digital Health Officer, Information Management Professional
ID
177

Speakers

Adam Greene, FHIMSS
Partner
Davis Wright Tremaine